Analysts at Goldman Sachs upgraded Mead Johnson Nutrition Company MJN from Neutral to Buy.
The target price for Mead Johnson Nutrition has been raised from $91 to $107.
Mead Johnson shares have jumped 26.13% over the past 52 weeks, while the S&P 500 index has gained 17.95% in the same period.
Mead Johnson's shares gained 0.30% to close at $92.87 yesterday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in